期刊文献+

1,25-二羟基维生素D3对脑室内注射链脲佐菌素大鼠认知功能和脑内cleaved-caspase-3表达的影响 被引量:1

The effect of 1,25-dihydroxy vitamin D3 on cognitive function and cleaved-caspase-3 expression in the model rats of Alzheimer type
原文传递
导出
摘要 目的 观察1,25-二羟基维生素D3对双侧脑室内注射链脲佐菌素(ICV-STZ)诱导阿尔茨海默病(AD)模型大鼠认识功能的影响,并探讨其作用机制.方法 36只SD大鼠随机分为3组:假手术组,模型组和治疗组.Morris水迷宫测试大鼠认知功能,比色法检测各组大鼠皮质和海马丙二醛(MDA)和谷胱甘肽(GSH)含量,免疫组织化学法检测脑内cleaved-caspase-3表达.结果 Morris水迷宫测试中,与假手术组大鼠逃逸潜伏期(秒)(10.31±2.33)比较,模型组大鼠逃逸潜伏期(36.54±4.56)显著延长,(P =0.000),治疗组(26.58±2.50)比模型组潜伏期显著缩短(P=0.003).与模型组大鼠皮质和海马MDA含量(nmol/mg)[(9.81±2.23),(5.09±0.74)]比较,治疗组大鼠皮质和海马MDA含量[(6.12±1.14),(3.77±0.41)]显著减少(P=0.001,P=0.002),与模型组大鼠皮质和海马GSH含量(g/L)[(1.57 ±0.56),(1.39±0.43)]比较,治疗组大鼠皮质和海马GSH含量[(2.98±0.52),(3.05±0.78)]显著增加(P =0.005,P=0.002).免疫组织化学染色显示,与模型组皮质和海马cleavedcaspase-3阳性细胞数[(32.47±8.22),(28.58±4.32)]比较,治疗组皮质和海马阳性细胞数[(16.85±7.31),(18.12±5.64)]显著减少(P=0.021,P=0.003).结论 1,25-二羟基维生素D3能够改善STZ诱导的大鼠认知功能障碍,其机制与改善脑内氧化应激和减少神经细胞凋亡有关. Objective To observe the effect of 1,25-dihydroxy vitamin D3 treatment on cognitive function of Alzheimer-type model rats and to investigate the mechanism.Methods 36 adult male SD rats were divided into 3 groups randomly:Sham group(s),Model group and Treatment group.The cognitive function was examined by Morris Water Maze test.The contents of malonaldehyde (MDA) and glutathione (GSH) were evaluated by the colorimetric method.Immunohistochemical method was used to assess the expression of cleavedcaspase-3.Results In Morris water maze test,compared with sham group (s) (10.31 ± 2.33),the escape latency of model group (36.54 ± 4.56) was significantly prelonged (P =0.000),compared with model group,the escape latency of treatment group (26.58 ± 2.50) was significantly shortened (P =0.003).Compared with model group(nmol/mg) [(9.81 ± 2.23),(5.09 ± 0.74)],the cortical and hippocampal MDA content of treatment group[(6.12 ± 1.14),(3.77 ± 0.41)] was decreased (P =0.001,P =0.002).Compared with model group(g/mL) [(1.57 ± 0.56),(1.39 ± 0.43)] the cortical and hippocampal GSH content of treatment group [(2.98 ± 0.52),(3.05 ± 0.78)] was increased (P =0.005,P =0.002).Compared with model group [(32.47 ± 8.22),(28.58 ± 4.32)],the expression of cortical and hippocampal cleaved-caspase-3 in treatment group [(16.85 ± 7.31),(18.12 ± 5.64)] was significantly increased (P =0.021,P =0.003).Conclusion 1,25-dihydroxy vitamin D3 treatment improved the cognitive dysfunction induced by STZ.This beneficial effect was implemented by ameliorating cerebral oxidative stress and reducing neuronal apoptosis.
出处 《国际免疫学杂志》 CAS 2016年第4期354-357,共4页 International Journal of Immunology
关键词 1 25-二羟基维生素D 阿尔茨海默病 氧化应激 认知障碍 1,25-dihydroxy vitamin D3 Alzheimer' s disease Oxidative stress Cognitive disorders
  • 相关文献

参考文献16

  • 1Zhang R, Naughton DP. Vitamin D in health and disease:current perspectives [ J]. Nutr J, 2010, ; 9 : 65. DOI : 10.1186/1475-2891 - 9-65.
  • 2Holick MF. Vitamin D deficiency [ J ]. N Engl J Med, 2007,357 ( 3 ) :266-281. DOI : 10. 1056/NEJMra070553.
  • 3周珊珊,刘丽娜,冯连荣,张黎明.依达拉奉对阿尔茨海默病模型大鼠认知损害的保护作用和脑内Bcl-2表达的影响[J].中风与神经疾病杂志,2011,28(8):708-711. 被引量:2
  • 4Zhou SS,Liu LN,Feng LR,et al. Effect of edaravone Bcl-2 expres- sion and brain protection effect on cognitive impairment of Alzheimer's disease model rats[ J]. J stroke neurol diso,2011,28 (8) :708-710.
  • 5Ulusoy HB, Sonmez MF, Kilic E, et al. Intraperitoneal Administra- tion of Low Dose Aluminium in The Rat : How Good is It to Produce a Model for Alzheimer Disease [ J ]. Arch Ital Biol,2015,153 (4) : 266-278. DOI : 10. 12871/00039829201543.
  • 6World Alzheimer Report 2013 : An analysis of long-term care for dementia [ EB ]. [ 2015-06-12 ]. http://wwwaizeouk/research/ WorldAlzheimerReport2013 pdf.
  • 7Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementi- a: a Delphi consensus study [ J ]. Lancet, 2005,366 ( 9503 ) : 2112- 2117. DOI: 10. 1016/S0140-6736 (05)67889-0.
  • 8Alzheimer's Association.. 2014 Alzheimer's disease facts and fig- ures [ J ]. Alzheimers Dement, 2014,10 ( 2 ) : 47-92. DOI : http :// dx. doi. org,/10. 1016/j. jalz. 2014.02. 001.
  • 9Murtishaw AS1, Heaney CF1, Bohon MM, et al, Effect of acute li- popolysacch aride-induced inflammation in streptozotocin injected rats [ J ]. Neuropharmacology, 2016, 101 : 110-122. doi : 10. 1016/j. neuropharm. 2015.08. 044.
  • 10Sharma V, Bala A, Deshmukh R, et al. Neuroprotective effect of RO-20-1724-aphosphodiesterase4 inhibitor against intracerebroven- tricular streptozotocin induced cognitive deficit and oxidative stress in rats[ J]. Pharmacol Biochem Behav,2012,101:239-245. DOI: 10. 1016/j. pbb. 2012.01. 004.

二级参考文献14

  • 1Weiss EM, Kohler CG, Vonbank J,et al. Impairment in emotion recognition abilities in patients with mild cognitive impairment, early and moderate Alzheimer disease compared with healthy comparison subjects[ J ]. Am J Geriatr Psychiatry ,2008,16 ( 12 ) :974 - 980.
  • 2Johnson DK ,Storandt M, Morris JC, et al. Cognitive profiles in dementia: Alzheimer disease vs. healthy brain aging [ J ]. Neurology, 2008, 71 (22) :1783 - 1789.
  • 3Sharma M, Gupta YK. Chronic treatment with trans resveratrol prevents intraeerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats[J]. Life Sci,2002,71 (21) :2489 -2498.
  • 4Morris R. Developments of a water-maze procedure for studying spatial learning in the rat [ J ]. J Neurosci Methods, 1984,11 ( 1 ) :47 -60.
  • 5Liu R, Liu l,Bi X, et al. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics[ J]. Proc Natl Acad Sci U S A,2003,100(14) :8526 -8531.
  • 6lshrat T,Parveen K,Khan MM,et al. Selenimn prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzhdmerg type [ J ]. Brain Res,2009,1281 : 117 - 127.
  • 7Lee HG,Casadesus G, Zhu X, et al. Challenging the amyloid cascade hypothesis senile plaques and amyloid-beta as protective adaptations to Alzheimer disease[ J]. Ann N Y Acad Sci ,2004,1019 : 1 -4.
  • 8Su B, Wang X, Lee HG, et al. Chronic oxidative stress causes increased tan phoshporylation in MI7 neumblastom a cell[ J ]. Neurosci Lett ,2010,1468 (3) :267 - 271.
  • 9Prickaerts J, Fahrig T, Blokland A. Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i. c.v. injection of streptozotocin: a correlation analysis [ J ]. Behav Brain Res, 1999,102 ( 1 - 2) :73 - 88.
  • 10Saini AK, Kumar HSA, Sharma SS. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy [ J ]. Eur J Pharmaeol,2007,568 ( 1 ~ 3 ) : 164 - 172.

共引文献1

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部